Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
The approval is backed by positive findings from three Phase III trials, a Phase II dose-ranging study, and two Phase I pharmacokinetic studies
This action is linked to the concentration of glucose in the blood, so glucagon secretion is suppressed in hyperglycemia conditions, but when hypoglycemia occurs, glucagon secretion increases
The active effects may be short, but detection windows can vary depending on dosage, frequency of use, metabolism, and testing methods
M., Doroodian, P., Gao, Z., Yu, P
US$ 25.96
US$ 27.41
US$ 20.24
